AMARIN CORP. PLC REG.SHS(SP.ADRS NEW)/1 LS-,50 (WK

NCE nach Jahren, drecks korrupte FDA, go Amarin go.....

http://finance.yahoo.com/news/...s-fda-chemical-entity-173000802.html  

http://finance.yahoo.com/news/...cosapent-ethyl-showed-150000344.html  

Neue Hochs bei den Verschreibungen und zum generischen Lovazza noch 4-facher Aufholbedarf, Vascepa wirkt besser und ist billiger:



06/10/2016 SCRIPTS
.

Prior week included Memorial Day.

Vascepa
TRx: 16.03k, up 6.9% from 14.99k
NRx: 6.53k, up 18.1% from 5.53k

Lovaza:
TRx: 2.42k, up 2.1% from 2.37k
NRx: 798, up 4.3% from 765

Generic L:
TRx: 61.82k, up 6.8% from 57.88k
NRx: 22.82k, up 13.8% from 20.06k Less
 

http://us.lrd.yahoo.com/...0%2520%2520%26utm_campaign=Stocktwits%2520  

http://finance.yahoo.com/m/...7f2/ss_3-risky-biotech-stocks-that.html  

Gute Zusammenfassung wie Amarin von der FDA beschissen wurde, jetzt wieder kaufen?

https://biotechinvesting.info/2016/07/18/...s-it-safe-to-get-back-in/  

Neue Hochs bei den Verschreibungen:

Scripts Update for Week Ending 15/07

V
TRx: 16,499 {vs 15,548; +6.12%} Sector +5.92%
NRx: 6,330 {vs 5,669; +11.66%} Sector +12.73%
Ref: 10,169 {vs 9,879; +2.94%} Sector +2.22% -- ATH

L
TRx: 2,174 {vs 2,123; +2.40%}
NRx: 929 {vs 827; +12.33%}

GenL
TRx: 60,488 {vs 57,069; +5.99%}
NRx: 22,369 {vs 19,786; +13.05%}

V TRx Market Share: 20.84% vs 20.80% -- = to ATH
V NRx Market Share: 21.36% vs 21.57% {ATH = 22.07%}
V Ref Market Share: 20.53% vs 20.39% -- ATH
 

Week Ending 22/07

V
TRx: 16,795 {vs 16,499; +1.79%} Sector -2.20% --- ATH
NRx: 6,693 {vs 6,330; +5.73%} Sector -1.62% --- ATH
Ref: 10,102 {vs 10,169; -0.66%} Sector -2.55% -- (ATH = 10,169)

L
TRx: 2,051 {vs 2,174; -5.66%}
NRx: 814 {vs 929; -12.38%}

GenL
TRx: 58,575 {vs 60,488; -3.16%}
NRx: 21,642 {vs 22,369; -3.25%}

V TRx Market Share: 21.69% vs 20.84% --- ATH
V NRx Market Share: 22.96% vs 21.36% --- ATH
V Ref Market Share: 20.93% vs 20.53% --- ATH
 

Short-Squeeeeeeeeeeeeeeeeeeezzzzzzzzzzzzzzzzzzzzzzeeeeeeeeeeeeeee­ee im Anmarsch?  

Das könnten die Gründe für den Kursanstieg unter hohem Volumen sein:

http://www.investorvillage.com/...mn=2204&pt=msg&mid=16223018  

Amarin als small cap buy:

http://www.fool.com/investing/2016/08/05/...cks-to-buy-in-august.aspx  

buy-out inevitable, guter Bericht:

https://biotechinvesting.info/2016/08/10/amarin-buyout-inevitable/  

Just in dem Moment twird eine Kapitalerhöhung durchgeführt, vielleicht eine gute Idee um Reducehttp://finance.yahoo.com/news/...ed-public-offering-201047701.html-It alleine erfolgreich durchzuziehen und nicht jetzt schon billig zu verkaufen:

 

Neue Hochs bei den Verschreibungen:

8/5 V Trx 17,459 vs 16,389. Nrx 6,902 vs 6,502. L TRx 2,290 vs 2,236. NRx 890 vs 835. Gen L TRx 60,967 vs 58,954. NRx 22,475 vs 21,
 

Neues PT,4,5 US Dollar, upside potential auf US Dollar 18:
https://drive.google.com/file/d/...Y6ODhRNTQ2T2VBUW8/view?usp=sharing
 

Amarin Empfehlung:

http://www.fool.com/investing/2016/09/24/...-2-to-buy-1-to-avoid.aspx  

Wieder empfehlen die fools Amarin:
https://finance.yahoo.com/m/...f/ss_5-small-cap-stocks-to-buy-in.html
 

Neue ATH`s bei den Verschreibungen, über 18.000 pro Woche:

Scripts Update for Week Ending 30/09
ATH ACROSS THE BOARD

V
TRx: 18,237 {vs 17,717; +2.94%} Sector +1.59% -- ATH
NRx: 7,223 {vs 6,923; +4.33%} Sector -0.08% -- ATH
Ref: 11,014 {vs 10,794; +2.04%} Sector +2.62% -- ATH

GenL
TRx: 60,393 {vs 59,855; +0.90%}
NRx: 22,453 {vs 22,830; -1.65%}

L
TRx: 2,244 {vs 2,040; +10.00%}
NRx: 790 {vs 738; +7.05%}

V TRx Market Share: 22.55% vs 22.25% -- ATH
V NRx Market Share: 23.71% vs 22.71% -- ATH  
V Ref Market Share: 21.85% vs 21.97% -- (ATH = 21.97%)  

Wieder neue ATH`s bei den Verschreibungen, dazu Blockbusterpotential mit Reduce-IT Studie:

Scripts Update for Week Ending 07/10

V
TRx: 18,611 {vs 18,237; +2.05%} Sector +1.94% -- ATH
NRx: 7,135 {vs 7,223; -1.22%} Sector +0.97%
Ref: 11,476 {vs 11,014; +4.19%} Sector +2.52% -- ATH

GenL
TRx: 61,644 {vs 60,393; +2.07%}
NRx: 22,792 {vs 22,453; +1.51%}

L
TRx: 2,187 {vs 2,244; -2.54%}
NRx: 835 {vs 790; +5.70%}

V TRx Market Share: 22.57% vs 22.55% -- ATH
V NRx Market Share: 23.19% vs 23.71% -- (ATH = 23.71%)
V Ref Market Share: 22.21% vs 21.85% -- ATH
 

Neues buy-Rating, US Dollar 5, bei Reduce-It Erfolg, US Dollar 16:

https://drive.google.com/file/d/...hhVHdUcnRVcVNhMnc/view?usp=sharing  

Hedgefond kauft 24.000.000 Amarin Aktien:

http://whalewisdom.com/filer/consonance-capital-management-lp  

Die Motely Fools empfehlen Amarin:

http://finance.yahoo.com/m/...s_penny-stocks%3A-2-to-buy%2C-2-to.html

 

Scripts Update for Week Ending 02/12
ATH ACROSS THE BOARD

V
TRx: 19,908 {vs 16,831; +18.28%} Sector +19.21% -- ATH
NRx: 7,620 {vs 5,992; +27.17%} Sector +26.70% -- ATH
Ref: 12,288 {vs 10,839; +13.37%} Sector +15.31% -- ATH

GenL
TRx: 63,081 {vs 52,781; +19.51%}
NRx: 22,636 {vs 17,814; +27.07%}

L
TRx: 2,197 {vs 1,848; +18.89%}
NRx: 745 {vs 663; +12.37%}

V TRx Market Share: 23.37% vs 23.55% -- (ATH=23.55%)
V NRx Market Share: 24.58% vs 24.49% -- ATH
V Ref Market Share: 22.68% vs 23.07% -- (ATH=23.07%)
 

Super Aussichten, Modelle von 5 US Dollar bis 26 US Dollar:

http://seekingalpha.com/article/...715f1981ac35bfc3be0d3&uprof=51  

könnte eine neue Übernehmendes Unternehmen werden in diesem oder nächsten Jahr.............nur meine Meinung....................